FC
LH icon

Farringdon Capital’s Labcorp LH Stock Holding History

Farringdon Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,180
Closed -$582K – 329
2026
Q1 		$582K Buy
+2,180
New +$590K 0.13% 207
2025
Q4 		– Sell
-1,013
Closed -$291K – 553
2025
Q3 		$291K Buy
+1,013
New +$271K 0.07% 332
2025
Q2 		– Sell
-4,227
Closed -$984K – 525
2025
Q1 		$984K Buy
+4,227
New +$1.03M 0.5% 38

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farringdon Capital's LH Position: Q2 2026 in Review

Farringdon Capital sold out of Labcorp (LH) in Q2 2026, closing a stake of 2,180 shares — an estimated $582K sold.

Farringdon Capital first reported a position in LH in Q1 2025 and held it in 3 quarters. The position peaked at $984K in Q1 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Farringdon Capital reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Farringdon Capital sold 2,180 Labcorp shares in Q2 2026, an estimated $582K.
  • Farringdon Capital first reported a position in Labcorp in Q1 2025 and held it in 3 quarters.
  • Farringdon Capital's Labcorp position peaked at $984K in Q1 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.